China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China
· Delayed Price · Currency is CNY 41.88
+0.84 (2.05%)
Mar 14, 2025, 2:45 PM CST
SHE:000999 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 3,368 | 2,853 | 2,449 | 2,055 | 1,597 | Upgrade
|
| Depreciation & Amortization | 838.2 | 786.67 | 522.66 | 478.75 | 390.19 | Upgrade
|
| Other Amortization | 62.06 | 117.91 | 48.75 | 45.84 | 36.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | -31.43 | -0.81 | -2.28 | -0.85 | 2.69 | Upgrade
|
| Asset Writedown & Restructuring Costs | 162.88 | 31.48 | 99.81 | 52.33 | 183.84 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 28.63 | -2.58 | -5.04 | -6.87 | Upgrade
|
| Provision & Write-off of Bad Debts | 94.05 | 55.04 | 5.53 | 13.63 | 19.84 | Upgrade
|
| Other Operating Activities | 414.78 | 474.62 | 102.6 | 200.43 | -71.77 | Upgrade
|
| Change in Accounts Receivable | -1,243 | 633.69 | -71.84 | -674.74 | 620.93 | Upgrade
|
| Change in Inventory | 67.83 | -966.01 | -59.69 | -652.26 | -286.76 | Upgrade
|
| Change in Accounts Payable | 682.7 | 315.29 | -21.86 | 458.43 | -241.06 | Upgrade
|
| Operating Cash Flow | 4,402 | 4,192 | 3,006 | 1,885 | 2,224 | Upgrade
|
| Operating Cash Flow Growth | 5.02% | 39.43% | 59.52% | -15.26% | 14.08% | Upgrade
|
| Capital Expenditures | -790.07 | -857.21 | -951.57 | -872.6 | -621.82 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.17 | 26.43 | 1.78 | 4.56 | 7.06 | Upgrade
|
| Cash Acquisitions | - | 953.63 | -11.76 | -120.63 | -1,005 | Upgrade
|
| Divestitures | - | 4.25 | - | - | 12.08 | Upgrade
|
| Investment in Securities | -324.16 | -953.36 | -1,584 | -870.37 | 782.24 | Upgrade
|
| Other Investing Activities | -21.35 | 32.77 | 66.4 | 66.74 | 166.28 | Upgrade
|
| Investing Cash Flow | -1,130 | -793.5 | -2,479 | -1,792 | -659.34 | Upgrade
|
| Long-Term Debt Issued | 1,007 | 3,578 | 593.69 | 97.97 | 204.97 | Upgrade
|
| Total Debt Issued | 1,007 | 3,578 | 593.69 | 97.97 | 204.97 | Upgrade
|
| Short-Term Debt Repaid | - | -17.05 | -1.45 | -3.1 | - | Upgrade
|
| Long-Term Debt Repaid | -2,682 | -1,930 | -520.27 | -105.43 | -1,252 | Upgrade
|
| Total Debt Repaid | -2,682 | -1,947 | -521.72 | -108.53 | -1,252 | Upgrade
|
| Net Debt Issued (Repaid) | -1,675 | 1,631 | 71.98 | -10.56 | -1,047 | Upgrade
|
| Issuance of Common Stock | 81.62 | - | 150.6 | 10.18 | - | Upgrade
|
| Common Dividends Paid | -2,960 | -1,056 | -855.78 | -505.66 | -424.36 | Upgrade
|
| Other Financing Activities | -75.48 | -124.98 | 57.75 | -162.98 | 2.64 | Upgrade
|
| Financing Cash Flow | -4,629 | 450.42 | -575.45 | -669.02 | -1,469 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.88 | 5.01 | 6.35 | -2.31 | -5.13 | Upgrade
|
| Net Cash Flow | -1,354 | 3,854 | -41.93 | -578.98 | 90.92 | Upgrade
|
| Free Cash Flow | 3,612 | 3,335 | 2,055 | 1,012 | 1,602 | Upgrade
|
| Free Cash Flow Growth | 8.32% | 62.28% | 103.03% | -36.83% | 13.54% | Upgrade
|
| Free Cash Flow Margin | 13.08% | 13.48% | 11.37% | 6.51% | 11.75% | Upgrade
|
| Free Cash Flow Per Share | 2.82 | 2.61 | 1.60 | 0.80 | 1.26 | Upgrade
|
| Cash Income Tax Paid | - | 2,762 | 1,839 | 1,919 | 1,717 | Upgrade
|
| Levered Free Cash Flow | 2,689 | 251.79 | 1,534 | 73.83 | 2,197 | Upgrade
|
| Unlevered Free Cash Flow | 2,739 | 302.28 | 1,547 | 82.7 | 2,200 | Upgrade
|
| Change in Net Working Capital | 209.59 | 2,010 | -187.68 | 952.86 | -1,213 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.